Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Solid Tumor 7Unspecified Adult Solid Tumor, Protocol Specific 3Mesothelioma 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Solid Tumors 1Solid Tumor, Adult 1Small Cell Lung Carcinoma 1Sarcoma 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Lymphoma, B-Cell 1Hematopoietic and Lymphoid System Neoplasm 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

pembrolizumab 6Nivolumab 3budigalimab 2Paclitaxel 2Ipilimumab 2Docetaxel 2venetoclax 1tislelizumab 1talazoparib 1spartalizumab 1rovalpituzumab tesirine 1regorafenib 1obinutuzumab 1naptumomab estafenatox 1fludarabine 1epacadostat 1durvalumab 1cabozantinib 1Platinum 1Levoleucovorin 1Leucovorin 1Interleukin-2 1IPI-549 1Gemcitabine 1Fluorodeoxyglucose F18 1Everolimus 1Cyclophosphamide 1Clinical Trials, Phase II as Topic 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Fluorodeoxyglucose F18 × Other solid neoplasm × Clear all
NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Stanford University

Phase 2 Completed
7 enrolled 6 charts
BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡